Member Info for hefonthefjords

I managed to buy at 19.65p through HL at 8:49am. No problem whatsoever.

I disagree, in fact what today's RNS tells us directly is that the product NEEDS to be global to satisfy the diversification criteria the funder has requested.
They want to see companies onboarded from a wider range of geographies before they commit their cash to them and, to me, that is not really an unreasonable stipulation to make on a possible €2.4bn investment.

It's basically a notification from the market saying that the price moved a lot more than expected. They commonly show up during volatile periods of trading in every share. They are not actually issued by the company so it's not really an RNS, or at least not the kind we as private investors are interested in.

They've kind of given away that the funder is UK based. Why else would they have a preference for UK common law operating geographies?

CORRECTION

Amazon are the third biggest company in the world i've just learned, after Saudi Aramco and Apple.
Always fact check yourself so you learn stuff. ;)

Kitty - That was a nice side effect of how Amazon marketed itself. Only selling books puts a sort of "high brow" slant on your business, giving it prestige by proxy of being associated with high learning and academia and all the exclusivity that comes with that.
Now they sell all the cr*p of the day from one gutter to another and are second biggest company in the world, right?

The thing that made amazon massive was that they realised people just want simple. See a thing. Click the button. It shows up shortly after. No problems. Cue the trillions of dollars rolling in.
To me, those are the only two ways to really make money in this world - make something that already exists simpler or make something entirely unheard of before.

SYME is the second category.

Dr100 - Completely different technologies. Difficult to draw comparisons between mRNA and traditional (whole inactivated, attenuated and toxoid) vaccines as they are fundamentally different approaches to generating immune response, thus testing and validation criteria are different.

A good analogy might be this;

You (the immune system) are sent to find and destroy all examples of an item from the shelves.

Traditional vaccines - I give you one of the actual items you are looking for to take with you for referencing against while you search.

mRNA vaccine - I teach you how to make a replica of only one part of the item for yourself so you can use that part you made as a reference against the parts of the items on the shelves and destroy the items that have that part.

So, you see, the mRNA design never gives the body any live virus, only the instructions on how part of it is constructed in order to recognise it. This is also why there is relatively little concern about covid mutations defeating the vaccine, because the part the mRNA vaccine teaches the immune system about is the part that makes covid so effective at spreading. If that part mutates too drastically, the vaccine won't be as effective, but likely neither will the virus.

Really pretty nifty stuff.

It's a super simplified analogy but that is the difference. The mRNA vaccine tech has also been in testing and developments for around 30 years before covid rolled around so it's not like there was no maturity in the technology before they went full bore with these vaccines on the public.
Again, simplified explanations for brevity. There's a lot of good reading on the topic out there if you care to find out more. Hope that knowing a bit more about it reassures you somewhat.

Honestly, I expected this to flop. It's the worst possible time to IPO a food delivery company when the economy is just about to begin a re-opening program that will see food deliveries tumble in number in relatively short order.
It's just unfortunate timing, I don't think it really reflects on the quality of their company.

I'd be pleased to even see a single mid to long term supply contract or any type of firm licensing deal or partnership for international manufacture.

I had hoped that was what we were going to see from the involvement of Volz Group but it seems like that channel has gone dead for some reason, with zero developments on that front reported since December as far as I've seen. Happy to be corrected if I've missed something on the Volz front...

Did anyone else spot that the eBay seller is an arts theatre?
Excellent market with the perfect use case scenario for a virus-killing mask that can work for 7 hours. Don't think there are many shows that last that long.

"as soon as practicable" is the wording.
If there is price sensitive news we should know about it within hours for this reason.

I don't expect an announcement of who the funder is until client companies already have cash in the bank. It would be seriously unwise to release that information until the deal is already completed. Imagine how damaging it would be if a name was announced and then the deal fell apart...

Without confirmed revenue from monetisation we are stuck here like a lost lamb wandering between 0.48p and 0.6p forever.
Onboarding fees may give a minor bump in price briefly but it will be flash in the pan because onboarding fees are not for revenue generation, they are for weeding out timewaster client companies, they are the cover charge for entry to the club.

No monetisation - no rocket. Simple as that. :(

Do the creditors' share allocations have lock-in periods on them the same as the rest of the Chrysaor issued shares will?
I'm not clear on that part anymore because as I understood the deal, all the new shares would have a lock in period of 6 - 12 months but now the discussion here makes it seem as though the creditors' shares won't have a lock-in period? Is that right?

My concern is that the creditors could dump 3bn shares on the market at 8am on April 1st and I don't see what incentive they have not to do that since they only took the shares option to avoid taking as big of a haircut on their dues from PMO.

The creditor shares after the merger I meant.... aren't they locked in for 6 -12 months after the merger, meaning there wont be a mass sell off by creditors on Apr 1st?

Aren't those shares tied in for 6 - 12 months though?

I agree that Wallbrook suck, but having had several experiences with PR agencies in my own life it's pretty much my default expectation that all PR agencies are pretty ineffectual and crap. They don't care about SYME and will literally do the bare minimum it takes to get their fees and that's it. They likely have a thousand other companies and clients to deal with at the same time, whom they equally care very little for and will do as little as is required to get paid for.
It's the way of the world.

The original question is legitimate and indeed is an answer we will need in time but the person in question had clearly already made up their own mind about the situation.

The thing that annoyed me though was that, after discussing the topic at length in a thread where multiple people suggested multiple possibilities, they started another thread that claimed nobody had addressed the issue...?

Idiots & time wasters.

I'm always up for a real discussion but the objective there was not to discuss or even, having made up their mind already, to just have an enjoyable argument on the issue. It was intended as a psych out for the lesser informed to weaken their position. Frankly, I find that in poor taste.

I think your valuation is wrong. According to this article, HE's anticipated valuation is $5bn.

Source: worldoil.com/news/2021/2/23/premier-oil-to-rejoin-uk-offshore-just-in-time-for-oil-price-surge

*** That could not happen if SYME were offering something it did not have.

I'm kinda rubbish at writing.